Northway Biotechpharma Celebrates 15 Years of Growth and Success
Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading
biopharmaceutical contract development and manufacturing organization
(CDMO), celebrates its 15th anniversary today. As a midsized CDMO,
Northway Biotechpharma is able to provide flexibility and responsiveness
backed by a strong foundation in science and technology. The company
focuses on understanding its customers and meeting their specific needs
without binding them to one single approach. It is able to react rapidly
to unexpected project changes, adjusting timelines, capacities and
other activities to meet its customers’ evolving needs. On average,
Northway Biotechpharma has 25–30 development projects underway each
year, ranging from gene cloning to final drug product manufacturing.
More info >> |